Address
Other Office
21 Waterway Avenue,
Suite 225
The Woodlands, TX 77380
United States
Phone
Website
VCID: 30232
Profile
Corporate information
Investment activity status
Active investor
Funds managed
| Fund | Type | Vintage |
|---|---|---|
| Essex Woodlands Health Ventures Fund VIII LP | 2008 |
|
| Essex Woodlands Health Ventures Fund V LP | 2000 |
Funding
Funding rounds
Cap Table
Current and past shareholders
| Investor | Round | |
|---|---|---|
|
Ascension Health Ventures LLC |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Kona Medical Inc Developer of non-invasive treatment for hypertension |
United States | 1 May 2012 | Series C Active |
|
|
|
IntegenX Inc Developing equipment for molecular diagnostics |
United States | 1 Dec 2011 | Series C |
|
|
Entellus Medical Inc Developer of innovative device technology and treatment to address the unmet needs of ENT physicians and their patients. |
United States | 1 Nov 2009 1 Oct 2011 |
Series E Active |
|
|
|
Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. |
United States | 1 Jan 2010 1 Jun 2011 |
Venture |
|
|
|
Symphogen |
Denmark | 1 Feb 2011 | Series F Follow-on investment. Round participant. Active |
|
|
|
NeoVista Inc |
United States | 1 Feb 2011 1 Mar 2009 |
Series E Follow-on investment. Round participant. Active |
|
|
|
Nellix Endovascular Inc |
United States | 13 Dec 2010 | N/A |
|
|
|
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Oct 2010 | Series F |
||
|
Accumetrics Inc Innovative developer and manufacturer of diagnostic instrumentation and test kits. |
United States | 1 Sep 2010 6 Oct 2009 21 Feb 2008 |
Venture Active |
|
|
Complete Genomics Inc |
United States | 1 Aug 2009 1 Aug 2010 |
Series E Active |
|
|
|
TearScience Inc Developer of a diagnostic and treatment devices targeted at the root cause of the majority of dry eye cases. |
United States | 1 May 2010 | Series C Active |
|
|
|
Oraya Therapeutics Inc Developing a radiation-based treatment for wet AMD |
United States | 1 Jul 2009 | Series C |
|
|
|
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. |
United States | 1 Dec 2008 | Series C |
|
|
|
Proteus Biomedical Inc Cardiac diagnostic devices |
United States | 1 Oct 2008 | Series D |